M. Valeria Bahamondes

ORCID: 0000-0001-5455-1236 · 5 papers in corpus
meta-analysis 2025
BMC women's health ·doi:10.1186/s12905-025-04157-5

BACKGROUND: Heavy menstrual bleeding (HMB) is defined as excessive menstrual blood loss that negatively affects physical, emotional, social, and quality of life (QoL) of women at reproductive age. The aim of this systematic scoping review w…

review 2015
Human Reproduction Update ·doi:10.1093/humupd/dmv023

BACKGROUND: Most contraceptive methods present benefits beyond contraception; however, despite a large body of evidence, many healthcare professionals (HCPs), users and potential users are unaware of those benefits. This review evaluates th…

observational 2011
Contraception ·doi:10.1016/j.contraception.2011.05.012

BACKGROUND: Despite the high contraceptive efficacy and the additional noncontraceptive benefits of the levonorgestrel-releasing intrauterine system (LNG-IUS), concerns persist with respect to its use in nulligravidas. The objective of this…

2011
·doi:10.1586/eog.11.43

Evaluation of: Jensen JT, Parke S, Mellinger U, Machlitt A, Fraser I. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstet. Gynecol. 117(4), 777–787 (2011).Heavy menstr…

review 2008
Expert review of medical devices ·doi:10.1586/17434440.5.4.437

This article provides a perspective on the use of the levonorgestrel-releasing intrauterine system as a contraceptive method and as therapy in different situations, as well as presenting the corresponding controversies and unresolved issues…